DLA Piper advises Quipt Home Medical in take-private buyout

DLA Piper advised home medical equipment provider Quipt Home Medical (Quipt) on its agreement to be acquired and taken private by affiliates of Kingswood Capital Management LP and Forager Capital Management LLC. Quipt shareholders will receive US$3.65 per share in cash and the transaction values Quipt at approximately US$260 million.

The transaction positions Quipt to accelerate its growth as a leader in end-to-end respiratory care, expanding its reach into strategic markets and enhancing its ability to serve patients nationwide.

“We’re proud to support Quipt in this milestone transaction, which unlocks new opportunities for growth and innovation,” said Larry Nishnick, Office Managing Partner and Co-Chair of the firm’s Southern California Corporate and Securities practice. “

“Having accompanied Quipt’s growth for over 15 years, we congratulate them on their meteoric rise as a trusted leader in respiratory care. We are excited to continue working with them as they complete this transformational transaction,” said Robbie Grossman, Corporate and Securities Partner in Toronto.

The cross-border DLA Piper team was led by Nishnick (Los Angeles/San Diego) in the US and Partners Robbie Grossman and Sydney A. Kert (both Toronto) in Canada.

With more than 1,000 corporate lawyers globally, DLA Piper helps clients execute complex transactions seamlessly while supporting clients across all stages of development. The firm has been rated number one in global M&A volume for 15 consecutive years by Mergermarket and ranked number one in VC, PE, and M&A in combined global deal volume by PitchBook.